陈德艳, 陈捷. 神经节苷脂治疗急性脑出血的疗效及对血清IL-1β、IL-6、IL-8水平的影响[J]. 实用临床医药杂志, 2014, (16): 116-119. DOI: 10.7619/jcmp.201416037
引用本文: 陈德艳, 陈捷. 神经节苷脂治疗急性脑出血的疗效及对血清IL-1β、IL-6、IL-8水平的影响[J]. 实用临床医药杂志, 2014, (16): 116-119. DOI: 10.7619/jcmp.201416037
CHEN Deyan, CHEN JIE. Curative effect of ganglioside on acute intracerebralhemorrhage interleukin-1β,(AICH)and its influence on serum IL-6 and IL-8 levels[J]. Journal of Clinical Medicine in Practice, 2014, (16): 116-119. DOI: 10.7619/jcmp.201416037
Citation: CHEN Deyan, CHEN JIE. Curative effect of ganglioside on acute intracerebralhemorrhage interleukin-1β,(AICH)and its influence on serum IL-6 and IL-8 levels[J]. Journal of Clinical Medicine in Practice, 2014, (16): 116-119. DOI: 10.7619/jcmp.201416037

神经节苷脂治疗急性脑出血的疗效及对血清IL-1β、IL-6、IL-8水平的影响

Curative effect of ganglioside on acute intracerebralhemorrhage interleukin-1β,(AICH)and its influence on serum IL-6 and IL-8 levels

  • 摘要: 目的:探讨神经节苷脂治疗急性脑出血的疗效及对血清 IL-1β、IL-6、IL-8水平的影响。方法选取2011年1月-2013年12月在本院神经科住院治疗的急性脑出血患者76例,采用数字表随机抽取法将入选患者分为观察组和对照组,每组38例。2组患者均予以酌情降颅压和血压、止血、抗感染和营养脑细胞等常规治疗,观察组患者加用神经节苷脂针60 mg静滴,1次/d,对照组患者加用孢磷胆碱钠针0.5g静滴,1次/d,2组均连用10d。观察2组患者治疗前后血清IL-1β、IL-6、IL-8水平的变化,并比较其临床疗效及药物不良反应。结果治疗10 d 后,2组患者血清 IL-1β、IL-6、IL-8水平较治疗前明显下降(P <0.05或P <0.01),且观察组下降幅度较对照组更明显(P <0.05);观察组患者临床总有效率明显高于对照组(94.74%与78.95%,χ2=4.15,P <0.05);对照组和观察组治疗中出现不良反应分别为2和4例,症状较轻,无严重的药物不良反应发生,2组患者不良反应发生率比较差异无统计学意义(χ2=0.18,P >0.05)。结论神经节苷脂治疗急性脑出血效果满意,安全性较好。作用机制可能为通过降低血清 IL-1β、IL-6、IL-8水平,抑制局部炎症反应而发挥对脑出血后继发脑损伤保护作用。

     

    Abstract: Objective To discuss curative effect of Ganglioside on acute intracerebral hem-orrhage (AICH)and its influence on serum interleukin-1β,IL-6 and IL-8 levels.Methods 76 pa-tients with AICH were divided into observation group and control group by random digital table method with 38 patients in each group.The patients in two groups were given routine medical treatment,such as reducing intracranial pressure and blood pressure,hemostasis,anti-infection, brain cells nutrition and so on.The patients in observation group were additionally given 60 mg Ganglioside by intravenous infusion for once a day,while the patients in control group were addi-tionally given 0.5 g Citicoline Sodium Injection by intravenous infusion,once a day for 10 days. The changes of serum IL-1β,IL-6 and IL-8 levels of patients in two groups before and after medi-cal treatment were observed,and the clinical curative effect and drug adverse reaction (DAR)were compared as well.Results After 10 days′medical treatment,the serum IL-1β,IL-6 and IL-8 lev-els of patients in two groups obviously declined than before (P <0.05 and P <0.01),and the de-clining rate in observation group was much higher than that in control group (P <0.05).The total clinical efficiency of patients in observation group was much higher than that in control group (94.74% vs.78.95%)(χ2=4.15,P <0.05).Adverse effect appeared in 2 and 4 patients in control group and observation group respectively during the medical treatment with light symptom and no serious DAR.After comparing the occurrence rates of adverse effect of patients in two groups,there was no statistical differences (χ2=0.18,P >0.05).Conclusion Ganglioside has favorable curative effect on AICH with high security,whose mechanism of action may inhibit lo-cal inflammatory response to protect the secondary brain injury after intracerebral hemorrhage by reducing the serum serum IL-1β,IL-6 and IL-8 levels.

     

/

返回文章
返回